Georgia Capital stock closed at £45.5 after Q3 2026 results, with the price already reflecting a market trying to process a complex story. On the surface, investors are staring at a company trading on a trailing P/E of 2.1x that sits well below both its industry and peer averages. The headline from this quarter is about valuation strain rather than earnings disappointment. Net asset value per share moved higher in the period and the discount to an estimated cash flow value of £67.01 now frames the real debate for anyone thinking beyond this week's move.
Love the deep value angle on Georgia Capital but uneasy about whether the discount is really justified by the underlying balance sheets? Compare it against our list of solid balance sheet and fundamentals stocks (10 results)
Q3 2026 Earnings Summary
-
Total Revenue (Q3 2026 vs. Q3 2025):55.464 million GEL vs. 113.815 million GEL (directionally lower in the latest quarter)
-
Net Income ex. Extra Items (Q3 2026 vs. Q3 2025):794.219 million GEL vs. 282.817 million GEL (very large increase in reported profit)
-
Basic EPS (Q3 2026 vs. Q2 2026):26.738406 GEL vs. 23.775672 GEL (up 12.5% quarter on quarter)
-
Trailing 12M Basic EPS (Q3 2026 vs. Q2 2026):72.703867 GEL vs. 51.361287 GEL (up 41.6% over the last quarter on a trailing basis)
Georgia Capital killed HoldCo debt and doubled buyback firepower. Ask Charlie what Georgia Capital's delevered balance sheet changes for buybacks .
Georgia Capital bullish story meets improving cash engine
For anyone leaning bullish on Georgia Capital, the latest quarter gives the thesis some support. Private portfolio revenue rose 18.5% year on year while EBITDA grew 26.3%, so the underlying businesses are throwing off more operating profit than top line. NAV per share moved up 13.6% in GEL, helped by both portfolio performance and currency. The HoldCo is now fully delevered and a fresh $50m buyback lifts available capacity to $100m. This reinforces the idea of an asset backed vehicle steadily turning portfolio earnings into shareholder capital returns.
Complexity, revenue drop and macro risk keep bears engaged
Caution still has real arguments. Reported Q3 revenue of 55.464m GEL is directionally lower than 113.815m GEL a year ago, which feeds concerns about volatile reported income and opaque fair value gains in a private equity structure. The stock is also exposed to Georgian macro and FX, even though recent data and Lari strength helped NAV this time. Segment detail shows strong pharmacy and healthcare metrics. Yet investors focused on clean, recurring earnings may still see a complex conglomerate where portfolio valuation and exit timing remain key open questions.
After a quarter where reported profit, fair value moves and Georgian macro all pull in different directions, it is easy to fixate on headline volatility and miss other structural weak spots. Review the independent risk analysis for Georgia Capital which shows 2 important warning signs to scan for hidden vulnerabilities, including insider behavior and margin trends, that may not be obvious.
Hunt For Quiet Mispricings
Georgia Capital just reminded investors how hard it is to interpret a complex holding company from one quarter. The real opportunity sits in finding stocks that could be undervalued before the market corrects them.
-
Company 1 - 39% below our estimate - targets higher fee private strategies so fee earning assets support more predictable cash generation.
-
Company 2 - 31% below our estimate - channels investor inflows into real asset and tax efficient products tied to infrastructure demand.
-
Company 3 - 21% below our estimate - expands production capacity and digital capabilities so complex defense programs and munitions orders convert backlog into cash.
Three companies from the same screener. Open every one of the 10 undervalued companies on it →
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include CGEO.L .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
